Search
for
Sort by
Research 841–870 of 1000+
- Application of Ethanol Extracts From Alnus sibirica Fisch. ex Turcz in Hair Growth Promotion
- A Scientific Hypothesis on the Role of Nutritional Supplements for Effective Management of Hair Loss and Promoting Hair Regrowth
- Therapeutic potential of Ishophloroglucin a from Ishige okamurae in androgenic alopecia: inhibition of 5α-reductase activity and activation of the Wnt/β-catenin signaling pathway in human dermal papilla cells
- Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia
- Current understanding and treatment of sex hormone-related hair diseases
- Development and evaluation of novel rodent model of PCOS mimicking clinical phenotype in human disease
- Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens
- Endocrine Functions of the Testes
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- Curcumin-zinc framework encapsulated microneedle patch for promoting hair growth
- Тіе Modern treatment of androgenetic alopecia
- Post-finasteride syndrome: An emerging clinical problem
- Bilateral temporal alopecia in male androgenetic alopecia: An unusual new presentation
- 5α-Reductase inhibitors in androgenetic alopecia
- Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress
- Unrevealing the Potential of Sansevieria trifasciata Prain Fraction for the Treatment of Androgenetic Alopecia by Inhibiting Androgen Receptors Based on LC-MS/MS Analysis, and In-Silico Studies
- Post-finasteride syndrome – does it really exist?
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Artificial Intelligence in Patient Education for Androgenetic Alopecia: A Comparative Study of ChatGPT, Gemini, and Deepseek R1
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- Antidepressant-like effect of fluoxetine may depend on translocator protein activity and pretest session duration in forced swimming test in mice
- Minoxidil: a comprehensive review
- Hair Loss in Women
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Post-finasteride syndrome
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.